Lisa Kalman

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Development of a genomic DNA reference material panel for Rett syndrome (MECP2-related disorders) genetic testing
    Lisa V Kalman
    Laboratory Research and Evaluation Branch, Centers for Disease Control and Prevention, Atlanta, Georgia Electronic address
    J Mol Diagn 16:273-9. 2014
  2. doi request reprint Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics
    Lisa V Kalman
    Laboratory Research and Evaluation Branch, Division of Laboratory Science and Standards, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Arch Pathol Lab Med 137:983-8. 2013
  3. pmc Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing
    Lisa Kalman
    Division of Laboratory Science and Standards, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Mol Diagn 15:518-25. 2013
  4. ncbi request reprint Development of genomic reference materials for Huntington disease genetic testing
    Lisa Kalman
    Laboratory Practice Evaluation and Genomics Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Genet Med 9:719-23. 2007
  5. pmc Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent
    Lisa Kalman
    Laboratory Practice Evaluation and Genomics Branch, National Center for Preparedness, Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop G23, Atlanta, GA 30333, USA
    J Mol Diagn 11:530-6. 2009
  6. pmc Quality assurance for Duchenne and Becker muscular dystrophy genetic testing: development of a genomic DNA reference material panel
    Lisa Kalman
    Division of Laboratory Science and Standards, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Mol Diagn 13:167-74. 2011
  7. doi request reprint Evaluation of the validity and utility of genetic testing for rare diseases
    Scott D Grosse
    Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Adv Exp Med Biol 686:115-31. 2010
  8. ncbi request reprint Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review
    Lisa Kalman
    Centers for Disease Control and Prevention, Newborn Screening Quality Assurance Program, Office of Genomics and Disease Prevention, Atlanta, Georgia, USA
    Genet Med 6:16-26. 2004

Detail Information

Publications8

  1. doi request reprint Development of a genomic DNA reference material panel for Rett syndrome (MECP2-related disorders) genetic testing
    Lisa V Kalman
    Laboratory Research and Evaluation Branch, Centers for Disease Control and Prevention, Atlanta, Georgia Electronic address
    J Mol Diagn 16:273-9. 2014
    ..Two of the 35 samples were from males with MECP2 duplications. These MECP2 and other characterized genomic DNA samples are publicly available from the NIGMS Repository at the Coriell Cell Repositories...
  2. doi request reprint Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics
    Lisa V Kalman
    Laboratory Research and Evaluation Branch, Division of Laboratory Science and Standards, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Arch Pathol Lab Med 137:983-8. 2013
    ..New PT/EQA approaches are needed to ensure the continued quality of these complex tests...
  3. pmc Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing
    Lisa Kalman
    Division of Laboratory Science and Standards, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Mol Diagn 15:518-25. 2013
    ..These samples are publicly available for quality control, proficiency testing, test development, and research and should help improve the accuracy of DM1 testing. ..
  4. ncbi request reprint Development of genomic reference materials for Huntington disease genetic testing
    Lisa Kalman
    Laboratory Practice Evaluation and Genomics Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Genet Med 9:719-23. 2007
    ....
  5. pmc Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent
    Lisa Kalman
    Laboratory Practice Evaluation and Genomics Branch, National Center for Preparedness, Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop G23, Atlanta, GA 30333, USA
    J Mol Diagn 11:530-6. 2009
    ..These characterized materials are publicly available from Coriell and may be used for quality control, proficiency testing, test development, and research...
  6. pmc Quality assurance for Duchenne and Becker muscular dystrophy genetic testing: development of a genomic DNA reference material panel
    Lisa Kalman
    Division of Laboratory Science and Standards, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Mol Diagn 13:167-74. 2011
    ....
  7. doi request reprint Evaluation of the validity and utility of genetic testing for rare diseases
    Scott D Grosse
    Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Adv Exp Med Biol 686:115-31. 2010
    ..Specific rare disorders addressed include cystic fibrosis, fragile X syndrome, Duchenne and Becker muscular dystrophy, spinal muscular atrophy, Huntington disease, as well as cancer associated with BRCA mutations...
  8. ncbi request reprint Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review
    Lisa Kalman
    Centers for Disease Control and Prevention, Newborn Screening Quality Assurance Program, Office of Genomics and Disease Prevention, Atlanta, Georgia, USA
    Genet Med 6:16-26. 2004
    ..Validated tests and pilot population studies are necessary to determine newborn screening's potential for identifying infants with SCID...